rs375459388
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000179.3(MSH6):c.3762A>C(p.Glu1254Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1254V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD4 exome Cov.: 33 
GnomAD4 genome  Cov.: 33 
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Uncertain:1 
The p.E1254D variant (also known as c.3762A>C), located in coding exon 8 of the MSH6 gene, results from an A to C substitution at nucleotide position 3762. The glutamic acid at codon 1254 is replaced by aspartic acid, an amino acid with highly similar properties. This alteration was reported as a somatic alteration in the lung cancer of a 78-year-old patient (Lin L et al. Int. J. Clin. Exp. Pathol. 2017;10(9):9583-9590). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. In addition, the CoDP in silico tool predicts this alteration to have a minor impact on molecular function, with a score of 0.027, and this alteration is predicted neutral by the PON-MMR in silico tool (Terui H et al. J. Biomed. Sci. 2013 Apr;20:25; Ali H et. al. Hum. Mutat. 2012 Apr;33:642-50). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at